சோபியா ஜெநெடிக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சோபியா ஜெநெடிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சோபியா ஜெநெடிக்ஸ் Today - Breaking & Trending Today

Teaming Up to Tackle Disease: This Week's Biopharma Collaborations


Published: Jul 07, 2021
By Alex Keown
Collaborations are part of the life’s blood of clinical development as biopharma and life sciences companies partner and pool resources to develop novel therapies and treatments for a myriad of diseases. 
This morning, multiple companies announced clinical and strategic collaborations. 
PureTech Health to Harness BeiGene’s Checkpoint Inhibitor
Boston-based PureTech Health plc and
forged an alliance to assess the combination of BeiGene’s experimental checkpoint inhibitor tislelizumab with
PureTech s LYT-200, an experimental monoclonal antibody targeting galectin-9, as a potential treatment for difficult-to-treat solid tumor indications that are associated with poor survival rates. Galectin-9 is a widely expressed immune modulator in multiple tumor types that are difficult-to-treat tumor types.  ....

United States , Ericl Smith , Sloan Kettering , Langone Health , Chronic Pain Fatigue Research Center , University Of Michigan , Puretech Health , Receptor Familyc Group , Puretech Health To Harness Beigene Checkpoint Inhibitor , Pharmaceuticals Strikes Licensing , Ge Healthcare , Tech Health , Harness Beigene , North America , Genetics Partners , Sophia Genetics , Licenses Eureka Asset , Eureka Therapeutics , Memorial Sloan Kettering , Memorial Sloan , Diego Based Tryp Therapeutics , Psilocybin For Neuropsychiatric Disorders , Chronic Pain , Fatigue Research Center , Reset Pharmaceuticals , Reset Pharmaceutical ,

SOPHiA GENETICS Advances Blood Cancer Genomic Testing With New Myeloid Solutions


SOPHiA GENETICS Advances Blood Cancer Genomic Testing With New Myeloid Solutions
Targets DNA variants and RNA fusion genes for blood cancers, including challenging variants CALR, CEBPA, ASXL1, FLT3
News provided by
Share this article
BOSTON and LAUSANNE, Switzerland, June 1, 2021 /PRNewswire/  
SOPHiA GENETICS, the creator of a global data-sharing network that advances data-driven medicine, today released SOPHiA DDM™ for Blood Cancers, novel blood cancer testing solutions across the entire workflow from setup, genomic testing, and in-house advanced analytics. The solutions target the most relevant DNA variants and RNA fusion genes for blood cancers, and come with SOPHiA DDM™ platform analysis, easing the identification of major biomarkers with secondary and tertiary analyses. ....

United States , Research Use , Smartest Companies Sophi , Blood Cancers , Solution Plus , Myeloid Solution , Vitro Diagnostic Usein Europe , Sophia Genetics , ஒன்றுபட்டது மாநிலங்களில் , ஆராய்ச்சி பயன்பாடு , இரத்தம் புற்றுநோய்கள் , தீர்வு ப்லஸ் , சோபியா ஜெநெடிக்ஸ் ,

Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors


Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors
My Personal Therapeutics Ltd. (trading as
Vivan Therapeutics), a global leader in personalised cancer therapeutics and in-vivo high throughput drug screening, is pleased to announce the addition of
Lilly Wollman to its distinguished board of directors.
Lilly Wollman is a seasoned team-builder and entrepreneurial leader with a 20-year track record in finance and investing. Currently, she is pursuing an MPhil in Computational Biology from the University of Cambridge and is dedicated to a second career solving complex problems in human health through the application of data science and machine intelligence. She is currently a research intern in the CRUK Early Detection Programme, and at the Milner Therapeutics Institute. ....

United Kingdom , City Of , San Francisco , United States , Lilly Wollman , Kostenloser Wertpapierhandel , Al Gore , Phi Beta Kappa , London Business School , Dartmouth College , Goldman Sachs , Vivan Therapeutics Ltd , Fortress Investment Group , University Of Cambridge , Prnewswire My Personal Therapeutics Ltd , Baupost Group , Mount Sinai Medical Center , Icahn School Of Medicine At Mount Sinai , Milner Therapeutics Institute , Commodities Division , Generation Investment Management , Early Detection Programme , Personal Therapeutics , Vivan Therapeutics , Computational Biology , Detection Programme ,